VJHemOnc is committed to improving our service to you

IMW 2019 | Are novel therapeutics replacing ASCT?

VJHemOnc is committed to improving our service to you

Hermann Einsele

Prof. Hermann Einsele, MD, FRCP, of the University of Würzburg, Würzburg, Germany, outlines which patient populations allogeneic stem cell transplantations (ASCT) are most relevant, and whether novel therapeutics now challenge this. This interview was recorded at the International Myeloma Workshop (IMW) 2019, in Boston, MA.

Share this video  
Similar topics

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter